Published in

Elsevier, Journal of Controlled Release, (262), p. 47-57, 2017

DOI: 10.1016/j.jconrel.2017.07.013

Links

Tools

Export citation

Search in Google Scholar

A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO